Major Depressive Disorder
Major Depressive Disorder (MDD), commonly referred to as clinical depression or major depression, is a mental health condition characterized by persistent feelings of sadness, hopelessness, and a loss of interest or pleasure in activities. It is a serious and debilitating condition that affects a person’s emotions, thoughts, and behaviors.
The exact cause of major depressive disorder is not fully understood, but it is believed to involve a complex interaction of genetic, biological, environmental, and psychological factors. Certain risk factors may increase the likelihood of developing depression, including a family history of the disorder, personal history of other mental health conditions, traumatic life events, chronic illness, substance abuse, and certain medications.
This magazine contains content which is gathered, validated, categorized, and supplied using a novel big data cyberinfrastructure technology that continually learns about Major Depressive Disorder.
-
Publication date: Dec 06, 2024 Extensive research, predominantly in adults, has highlighted structural brain variations ...
-
Variability in emotion regulation strategy use in major depressive disorder: Flexibility or volatility?
Publication date: Dec 06, 2024 Emotion regulation is critical for psychological health. Adaptive emotion regulation, ... -
Bereaved family quality of life varies with comorbid psychological distress and ICU-care quality.
Publication date: Dec 06, 2024 Health-related quality of life (HRQOL) is highly endorsed, but HRQOL ... -
The efficacy and cerebral mechanism of intradermal acupuncture for major depressive disorder: a multicenter randomized controlled trial.
Publication date: Dec 08, 2024 New combinations or alternative therapies for major depressive disorder (MDD) ... -
Exhaustion Disorder in Primary Care: A Comparison With Major Depressive Disorder and Adjustment Disorder.
Publication date: Dec 08, 2024 Exhaustion disorder (ED) was introduced to the Swedish version of ... -
Four weeks standard vs. one week accelerated intermittent Theta Burst Stimulation for the treatment of depression – A retrospective analysis.
Publication date: Feb 28, 2025 Intermittent Theta Burst Stimulation (iTBS), a specific form of repetitive ... -
Discovery of potential female-specific biomarkers for major depressive disorder by LC-MS-based metabolomics.
Publication date: Feb 15, 2025 The prevalence of major depressive disorder (MDD) is higher in ... -
Rumination, loneliness, and non-suicidal self-injury among adolescents with major depressive disorder: The moderating role of resilience.
Publication date: Jan 01, 2025 Adolescents often experience negative emotions, such as depression and anxiety, ... -
Acceptability, tolerability and safety of the BRIGhTMIND trial: Connectivity-guided intermittent theta-burst stimulation versus F3- repetitive transcranial magnetic stimulation for treatment-resistant depression.
Publication date: Jan 01, 2025 The BRIGhTMIND study was a double-blind RCT comparing repetitive transcranial ... -
Exhaustion Disorder in Primary Care: A Comparison With Major Depressive Disorder and Adjustment Disorder.
Publication date: Dec 09, 2024 The study aimed to investigate the discriminative validity of ED ... -
Comparison of overall survival and healthcare resource utilization among patients with major depressive disorder with or without psychiatric emergency admission: A real-world study from Hungary.
Publication date: Dec 05, 2024 Patients with major depressive disorder (MDD) hospitalized for psychiatric emergencies ... -
Examining the impact of comorbid posttraumatic stress disorder on ketamine’s real-world effectiveness in treatment-resistant depression.
Publication date: Dec 05, 2024 Depression with comorbid posttraumatic stress disorder (PTSD) is associated with ... -
Factors influencing suicidal ideation among female adolescents with smoking experience: A cross-sectional study using National Big Data.
Publication date: Dec 05, 2024 This study aimed to investigate the factors influencing suicidal ideation ... -
Altered brain regional homogeneity, depressive symptoms, and cognitive impairments in medication-free female patients with current depressive episodes in bipolar disorder and major depressive disorder.
Publication date: Dec 06, 2024 Although symptoms of depressive episodes in patients with bipolar depressive ... -
Genome-wide methylome-based molecular pathologies associated with depression and suicide.
Publication date: Dec 07, 2024 Major depressive disorder (MDD) is a debilitating disorder. Suicide attempts ... -
Metacognitive beliefs and desire thinking as potential maintenance factors of compulsive sexual behavior.
Publication date: Feb 01, 2025 Using the Elaborated Intrusion Theory of Desire and the Self-Regulatory ... -
Poor Sleep is Common in Treatment-Resistant Late-life Depression and Associated With Poorer Antidepressant Response: Findings From the OPTIMUM Clinical Trial.
Publication date: Jan 01, 2025 Adults with treatment-resistant late-life depression (TRLLD) have high rates of ... -
Late Life Depression is Not Associated With Alzheimer-Type Tau: Preliminary Evidence From a Next-Generation Tau Ligand PET-MR Study.
Publication date: Jan 01, 2025 To investigate whether tau accumulation is higher in late life ... -
Spermidine alleviates depression via control of the stress response
Publication date: Dec 06, 2024 Depression is a stress-associated disorder, and it represents a major ... -
Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.
Publication date: Dec 01, 2024 The individual efficacy and safety of intravenous racemic (IV) ketamine, ... -
The Potential Role of Dopamine Pathways in the Pathophysiology of Depression: Current Advances and Future Aspects.
Publication date: Dec 05, 2024 Depression is a serious mental health disorder that impacts more ...